Figures & data
Table 1 Characteristics of study participants
Table 2 Application of 18F-FDG PET/CT and CA19-9 in differentially diagnosing PC from CMFP
Figure 1 Images of a male participant, 69 years.
Notes: Computed tomography showed that there was a suspicious lesion in his pancreas. His carbohydrate antigen 19-9 level was 51.68. 18F-FDG PET/CT showed that there was no lesion with increased 18F-FDG uptake in his pancreas. Finally, he was diagnosed with chronic mass-forming pancreatitis. (A) Pancreatic head lesion in computed tomography; (B) pancreatic head lesion in 18F-FDG PET/CT; (C) pancreatic duct dilatation in computed tomography; and (D) pancreatic duct dilatation in 18F-FDG PET/CT.
Abbreviations: PET, positron emission tomography; CT, computed tomography.
![Figure 1 Images of a male participant, 69 years.Notes: Computed tomography showed that there was a suspicious lesion in his pancreas. His carbohydrate antigen 19-9 level was 51.68. 18F-FDG PET/CT showed that there was no lesion with increased 18F-FDG uptake in his pancreas. Finally, he was diagnosed with chronic mass-forming pancreatitis. (A) Pancreatic head lesion in computed tomography; (B) pancreatic head lesion in 18F-FDG PET/CT; (C) pancreatic duct dilatation in computed tomography; and (D) pancreatic duct dilatation in 18F-FDG PET/CT.Abbreviations: PET, positron emission tomography; CT, computed tomography.](/cms/asset/8683e984-e6a9-4f44-bbb7-5c81f7ce8e70/dcia_a_115254_f0001_c.jpg)
Figure 2 Images of a female participant, 66 years.
Abbreviations: PET, positron emission tomography; CT, computed tomography.
![Figure 2 Images of a female participant, 66 years.](/cms/asset/6d729dcb-0511-4308-a570-06f11700d1d0/dcia_a_115254_f0002_c.jpg)